Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 27 entries
Sorted by: Best Match Show Resources per page
Ingrown toenails (unguis incarnatus): Nail braces/bracing treatment.

Proceedings (Baylor University. Medical Center)

Chiriac A, Solovan C, Brzezinski P.
PMID: 24688206
Proc (Bayl Univ Med Cent). 2014 Apr;27(2):145. doi: 10.1080/08998280.2014.11929093.

Nail bracing is a safe, simple, and inexpensive treatment option that avoids surgery, requires no anesthetic, requires no recovery period, allows wearing the existing shoes, offers immediate relief from pain, and allows the practice of daily activities. Braces can...

Cite
Chiriac A, Solovan C, Brzezinski P. Ingrown toenails (unguis incarnatus): Nail braces/bracing treatment. Proc (Bayl Univ Med Cent). 2014;27(2):145doi: 10.1080/08998280.2014.11929093.
Chiriac, A., Solovan, C., & Brzezinski, P. (2014). Ingrown toenails (unguis incarnatus): Nail braces/bracing treatment. Proceedings (Baylor University. Medical Center), 27(2), 145. https://doi.org/10.1080/08998280.2014.11929093
Chiriac, Anca, et al. "Ingrown toenails (unguis incarnatus): Nail braces/bracing treatment." Proceedings (Baylor University. Medical Center) vol. 27,2 (2014): 145. doi: https://doi.org/10.1080/08998280.2014.11929093
Chiriac A, Solovan C, Brzezinski P. Ingrown toenails (unguis incarnatus): Nail braces/bracing treatment. Proc (Bayl Univ Med Cent). 2014 Apr;27(2):145. doi: 10.1080/08998280.2014.11929093. PMID: 24688206; PMCID: PMC3954676.
Copy Download .nbib Format: NLM
Spectral characteristics of the mutant form GGBP/H152C of D-glucose/D-galactose-binding protein labeled with fluorescent dye BADAN: influence of external factors.

PeerJ

Fonin AV, Stepanenko OV, Povarova OI, Volova CA, Philippova EM, Bublikov GS, Kuznetsova IM, Demchenko AP, Turoverov KK.
PMID: 24711960
PeerJ. 2014 Mar 18;2:e275. doi: 10.7717/peerj.275. eCollection 2014.

The mutant form GGBP/H152C of the D-glucose/D-galactose-binding protein with the solvatochromic dye BADAN linked to cysteine residue Cys 152 can be used as a potential base for a sensitive element of glucose biosensor system. We investigated the influence of...

Cite
Fonin AV, Stepanenko OV, Povarova OI, et al. Spectral characteristics of the mutant form GGBP/H152C of D-glucose/D-galactose-binding protein labeled with fluorescent dye BADAN: influence of external factors. PeerJ. 2014;2:e275doi: 10.7717/peerj.275.
Fonin, A. V., Stepanenko, O. V., Povarova, O. I., Volova, C. A., Philippova, E. M., Bublikov, G. S., Kuznetsova, I. M., Demchenko, A. P., & Turoverov, K. K. (2014). Spectral characteristics of the mutant form GGBP/H152C of D-glucose/D-galactose-binding protein labeled with fluorescent dye BADAN: influence of external factors. PeerJ, 2e275. https://doi.org/10.7717/peerj.275
Fonin, Alexander V, et al. "Spectral characteristics of the mutant form GGBP/H152C of D-glucose/D-galactose-binding protein labeled with fluorescent dye BADAN: influence of external factors." PeerJ vol. 2 (2014): e275. doi: https://doi.org/10.7717/peerj.275
Fonin AV, Stepanenko OV, Povarova OI, Volova CA, Philippova EM, Bublikov GS, Kuznetsova IM, Demchenko AP, Turoverov KK. Spectral characteristics of the mutant form GGBP/H152C of D-glucose/D-galactose-binding protein labeled with fluorescent dye BADAN: influence of external factors. PeerJ. 2014 Mar 18;2:e275. doi: 10.7717/peerj.275. eCollection 2014. PMID: 24711960; PMCID: PMC3970809.
Copy Download .nbib Format: NLM
Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review.

Infectious diseases and therapy

Solovan C, Chiticariu E.
PMID: 25135824
Infect Dis Ther. 2013 Jun;2(1):59-73. doi: 10.1007/s40121-013-0003-9. Epub 2013 Feb 15.

INTRODUCTION: The era of biologic therapies has provided new options for the treatment of chronic plaque psoriasis. However, safety concerns have led to intensive screening and monitoring of patients receiving anti-tumor necrosis factor alpha (anti-TNF-alpha) agents.METHODS: The authors describe...

Cite
Solovan C, Chiticariu E. Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review. Infect Dis Ther. 2013;2(1):59-73doi: 10.1007/s40121-013-0003-9.
Solovan, C., & Chiticariu, E. (2013). Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review. Infectious diseases and therapy, 2(1), 59-73. https://doi.org/10.1007/s40121-013-0003-9
Solovan, Caius, and Chiticariu, Elena. "Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review." Infectious diseases and therapy vol. 2,1 (2013): 59-73. doi: https://doi.org/10.1007/s40121-013-0003-9
Solovan C, Chiticariu E. Psoriasis, anti-tumor necrosis factor therapy, and tuberculosis: report of three challenging cases and literature review. Infect Dis Ther. 2013 Jun;2(1):59-73. doi: 10.1007/s40121-013-0003-9. Epub 2013 Feb 15. PMID: 25135824; PMCID: PMC4108098.
Copy Download .nbib Format: NLM
Psoriasis and tuberculosis binomial distribution?.

Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences

Chiriac A, Foia L, Chiriac AE, Pinteala T, Solovan C, Brzezinski P.
PMID: 25097634
J Res Med Sci. 2014 May;19(5):477.

No abstract available.

Cite
Chiriac A, Foia L, Chiriac AE, et al. Psoriasis and tuberculosis binomial distribution?. J Res Med Sci. 2014;19(5):477
Chiriac, A., Foia, L., Chiriac, A. E., Pinteala, T., Solovan, C., & Brzezinski, P. (2014). Psoriasis and tuberculosis binomial distribution?. Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences, 19(5), 477.
Chiriac, Anca, et al. "Psoriasis and tuberculosis binomial distribution?." Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences vol. 19,5 (2014): 477.
Chiriac A, Foia L, Chiriac AE, Pinteala T, Solovan C, Brzezinski P. Psoriasis and tuberculosis binomial distribution?. J Res Med Sci. 2014 May;19(5):477. PMID: 25097634; PMCID: PMC4116583.
Copy Download .nbib Format: NLM
Improved Personalised Neuroendocrine Tumours' Diagnosis Predictive Power by New Receptor Somatostatin Image Processing Quantification.

Journal of personalized medicine

Stolniceanu CR, Moscalu M, Azoicai D, Tamba B, Volovat C, Grierosu I, Ionescu T, Jalloul W, Ghizdovat V, Gherasim R, Volovat S, Wang F, Fu J, Moscalu R, Matovic M, Stefanescu C.
PMID: 34683183
J Pers Med. 2021 Oct 17;11(10). doi: 10.3390/jpm11101042.

Although neuroendocrine tumours (NETs) are intensively studied, their diagnosis and consequently personalised therapy management is still puzzling due to their tumoral heterogeneity. In their theragnosis algorithm, receptor somatostatin scintigraphy takes the central place, the diagnosis receptor somatostatin analogue (RSA)...

Cite
Stolniceanu CR, Moscalu M, Azoicai D, et al. Improved Personalised Neuroendocrine Tumours' Diagnosis Predictive Power by New Receptor Somatostatin Image Processing Quantification. J Pers Med. 2021;11(10)doi: 10.3390/jpm11101042.
Stolniceanu, C. R., Moscalu, M., Azoicai, D., Tamba, B., Volovat, C., Grierosu, I., Ionescu, T., Jalloul, W., Ghizdovat, V., Gherasim, R., Volovat, S., Wang, F., Fu, J., Moscalu, R., Matovic, M., & Stefanescu, C. (2021). Improved Personalised Neuroendocrine Tumours' Diagnosis Predictive Power by New Receptor Somatostatin Image Processing Quantification. Journal of personalized medicine, 11(10), . https://doi.org/10.3390/jpm11101042
Stolniceanu, Cati Raluca, et al. "Improved Personalised Neuroendocrine Tumours' Diagnosis Predictive Power by New Receptor Somatostatin Image Processing Quantification." Journal of personalized medicine vol. 11,10 (2021). doi: https://doi.org/10.3390/jpm11101042
Stolniceanu CR, Moscalu M, Azoicai D, Tamba B, Volovat C, Grierosu I, Ionescu T, Jalloul W, Ghizdovat V, Gherasim R, Volovat S, Wang F, Fu J, Moscalu R, Matovic M, Stefanescu C. Improved Personalised Neuroendocrine Tumours' Diagnosis Predictive Power by New Receptor Somatostatin Image Processing Quantification. J Pers Med. 2021 Oct 17;11(10). doi: 10.3390/jpm11101042. PMID: 34683183; PMCID: PMC8539645.
Copy Download .nbib Format: NLM
Efficacy of Slow-Release Formulations of Metribuzin and Tribenuron Methyl Herbicides for Controlling Weeds of Various Species in Wheat and Barley Stands.

ACS omega

Volova T, Shumilova A, Zhila N, Sukovatyi A, Shishatskaya E, Thomas S.
PMID: 33043192
ACS Omega. 2020 Sep 23;5(39):25135-25147. doi: 10.1021/acsomega.0c02492. eCollection 2020 Oct 06.

The herbicidal activity of long-acting formulations of metribuzin and tribenuron methyl herbicides embedded in granules prepared from a mixture of degradable poly(3-hydroxybutyrate) and birch wood flour was studied in laboratory-grown weeds of various species and in wheat

Cite
Volova T, Shumilova A, Zhila N, et al. Efficacy of Slow-Release Formulations of Metribuzin and Tribenuron Methyl Herbicides for Controlling Weeds of Various Species in Wheat and Barley Stands. ACS Omega. 2020;5(39):25135-25147doi: 10.1021/acsomega.0c02492.
Volova, T., Shumilova, A., Zhila, N., Sukovatyi, A., Shishatskaya, E., & Thomas, S. (2020). Efficacy of Slow-Release Formulations of Metribuzin and Tribenuron Methyl Herbicides for Controlling Weeds of Various Species in Wheat and Barley Stands. ACS omega, 5(39), 25135-25147. https://doi.org/10.1021/acsomega.0c02492
Volova, Tatiana, et al. "Efficacy of Slow-Release Formulations of Metribuzin and Tribenuron Methyl Herbicides for Controlling Weeds of Various Species in Wheat and Barley Stands." ACS omega vol. 5,39 (2020): 25135-25147. doi: https://doi.org/10.1021/acsomega.0c02492
Volova T, Shumilova A, Zhila N, Sukovatyi A, Shishatskaya E, Thomas S. Efficacy of Slow-Release Formulations of Metribuzin and Tribenuron Methyl Herbicides for Controlling Weeds of Various Species in Wheat and Barley Stands. ACS Omega. 2020 Sep 23;5(39):25135-25147. doi: 10.1021/acsomega.0c02492. eCollection 2020 Oct 06. PMID: 33043192; PMCID: PMC7542591.
Copy Download .nbib Format: NLM
A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer.

Oncotarget

Volovat SR, Ciuleanu TE, Koralewski P, Olson JEG, Croitoru A, Koynov K, Stabile S, Cerea G, Osada A, Bobe I, Volovat C.
PMID: 32913555
Oncotarget. 2020 Aug 18;11(33):3105-3117. doi: 10.18632/oncotarget.27684. eCollection 2020 Aug 18.

NC-6004 is a nanoparticle developed using micellar technology that can improve release of cisplatin, a standard treatment for many cancer types, and achieve selective distribution to tumors. Here, in the Phase II portion of this study, the activity, safety,...

Cite
Volovat SR, Ciuleanu TE, Koralewski P, et al. A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer. Oncotarget. 2020;11(33):3105-3117doi: 10.18632/oncotarget.27684.
Volovat, S. R., Ciuleanu, T. E., Koralewski, P., Olson, J. E. G., Croitoru, A., Koynov, K., Stabile, S., Cerea, G., Osada, A., Bobe, I., & Volovat, C. (2020). A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer. Oncotarget, 11(33), 3105-3117. https://doi.org/10.18632/oncotarget.27684
Volovat, Simona Ruxandra, et al. "A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer." Oncotarget vol. 11,33 (2020): 3105-3117. doi: https://doi.org/10.18632/oncotarget.27684
Volovat SR, Ciuleanu TE, Koralewski P, Olson JEG, Croitoru A, Koynov K, Stabile S, Cerea G, Osada A, Bobe I, Volovat C. A multicenter, single-arm, basket design, phase II study of NC-6004 plus gemcitabine in patients with advanced unresectable lung, biliary tract, or bladder cancer. Oncotarget. 2020 Aug 18;11(33):3105-3117. doi: 10.18632/oncotarget.27684. eCollection 2020 Aug 18. PMID: 32913555; PMCID: PMC7443368.
Copy Download .nbib Format: NLM
Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy.

SpringerPlus

Volovat C, Bondarenko IM, Gladkov OA, Elsässer R, Buchner A, Bias P, Müller U.
PMID: 26155455
Springerplus. 2015 Jul 03;4:316. doi: 10.1186/s40064-015-1067-7. eCollection 2015.

PURPOSE: The aim of this study was to demonstrate lipegfilgrastim superiority versus placebo in adults with non-small cell lung cancer receiving myelosuppressive chemotherapy.METHODS: This phase III, double-blind study randomized chemotherapy-naive patients to receive cisplatin and etoposide with either lipegfilgrastim...

Cite
Volovat C, Bondarenko IM, Gladkov OA, et al. Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy. Springerplus. 2015;4:316doi: 10.1186/s40064-015-1067-7.
Volovat, C., Bondarenko, I. M., Gladkov, O. A., Elsässer, R., Buchner, A., Bias, P., & Müller, U. (2015). Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy. SpringerPlus, 4316. https://doi.org/10.1186/s40064-015-1067-7
Volovat, Constantin, et al. "Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy." SpringerPlus vol. 4 (2015): 316. doi: https://doi.org/10.1186/s40064-015-1067-7
Volovat C, Bondarenko IM, Gladkov OA, Elsässer R, Buchner A, Bias P, Müller U. Phase III, randomized, double-blind, placebo-controlled, multicenter study of lipegfilgrastim in patients with non-small cell lung cancer receiving myelosuppressive therapy. Springerplus. 2015 Jul 03;4:316. doi: 10.1186/s40064-015-1067-7. eCollection 2015. PMID: 26155455; PMCID: PMC4489970.
Copy Download .nbib Format: NLM
Raman Spectroscopy of Changes in the Tissues of Teeth with Periodontitis.

Diagnostics (Basel, Switzerland)

Timchenko E, Timchenko P, Volova L, Frolov O, Zibin M, Bazhutova I.
PMID: 33126522
Diagnostics (Basel). 2020 Oct 28;10(11). doi: 10.3390/diagnostics10110876.

The results of experimental studies of the tissues of teeth with periodontitis, using the Raman spectroscopy method, are presented in this work. Spectral changes in the tissues of teeth with periodontitis were identified, and the results can be used...

Cite
Timchenko E, Timchenko P, Volova L, et al. Raman Spectroscopy of Changes in the Tissues of Teeth with Periodontitis. Diagnostics (Basel). 2020;10(11)doi: 10.3390/diagnostics10110876.
Timchenko, E., Timchenko, P., Volova, L., Frolov, O., Zibin, M., & Bazhutova, I. (2020). Raman Spectroscopy of Changes in the Tissues of Teeth with Periodontitis. Diagnostics (Basel, Switzerland), 10(11), . https://doi.org/10.3390/diagnostics10110876
Timchenko, Elena, et al. "Raman Spectroscopy of Changes in the Tissues of Teeth with Periodontitis." Diagnostics (Basel, Switzerland) vol. 10,11 (2020). doi: https://doi.org/10.3390/diagnostics10110876
Timchenko E, Timchenko P, Volova L, Frolov O, Zibin M, Bazhutova I. Raman Spectroscopy of Changes in the Tissues of Teeth with Periodontitis. Diagnostics (Basel). 2020 Oct 28;10(11). doi: 10.3390/diagnostics10110876. PMID: 33126522; PMCID: PMC7692199.
Copy Download .nbib Format: NLM
MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review.

Frontiers in oncology

Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, Grigorescu C, Stefanescu C, Volovat CC, Augustin I.
PMID: 33330019
Front Oncol. 2020 Nov 20;10:526850. doi: 10.3389/fonc.2020.526850. eCollection 2020.

Noncoding RNAs (ncRNAs) include a diverse range of RNA species, including microRNAs (miRNAs) and long noncoding RNAs (lncRNAs). MiRNAs, ncRNAs of approximately 19-25 nucleotides in length, are involved in gene expression regulation either via degradation or silencing of the...

Cite
Volovat SR, Volovat C, Hordila I, et al. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol. 2020;10:526850doi: 10.3389/fonc.2020.526850.
Volovat, S. R., Volovat, C., Hordila, I., Hordila, D. A., Mirestean, C. C., Miron, O. T., Lungulescu, C., Scripcariu, D. V., Stolniceanu, C. R., Konsoulova-Kirova, A. A., Grigorescu, C., Stefanescu, C., Volovat, C. C., & Augustin, I. (2020). MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Frontiers in oncology, 10526850. https://doi.org/10.3389/fonc.2020.526850
Volovat, Simona Ruxandra, et al. "MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review." Frontiers in oncology vol. 10 (2020): 526850. doi: https://doi.org/10.3389/fonc.2020.526850
Volovat SR, Volovat C, Hordila I, Hordila DA, Mirestean CC, Miron OT, Lungulescu C, Scripcariu DV, Stolniceanu CR, Konsoulova-Kirova AA, Grigorescu C, Stefanescu C, Volovat CC, Augustin I. MiRNA and LncRNA as Potential Biomarkers in Triple-Negative Breast Cancer: A Review. Front Oncol. 2020 Nov 20;10:526850. doi: 10.3389/fonc.2020.526850. eCollection 2020. PMID: 33330019; PMCID: PMC7716774.
Copy Download .nbib Format: NLM
Assessment of the efficacy of slow-release formulations of the tribenuron-methyl herbicide in field-grown spring wheat.

Environmental science and pollution research international

Volova TG, Kurachenko NL, Bopp VL, Thomas S, Demidenko AV, Kiselev EG, Baranovsky SV, Sukovatyi AG, Zhila NO, Shishatskaya EI.
PMID: 34727312
Environ Sci Pollut Res Int. 2021 Nov 02; doi: 10.1007/s11356-021-17195-x. Epub 2021 Nov 02.

The efficacy of slow-release formulations of tribenuron-methyl (TBM) embedded in the matrix of degradable poly(3-hydroxybutyrate) blended with birch wood flour [polymer/wood flour/herbicide 50/30/20 wt.%] was compared with the efficacy of TBM as the active ingredient of the Mortira commercial...

Cite
Volova TG, Kurachenko NL, Bopp VL, et al. Assessment of the efficacy of slow-release formulations of the tribenuron-methyl herbicide in field-grown spring wheat. Environ Sci Pollut Res Int. 2021;doi: 10.1007/s11356-021-17195-x.
Volova, T. G., Kurachenko, N. L., Bopp, V. L., Thomas, S., Demidenko, A. V., Kiselev, E. G., Baranovsky, S. V., Sukovatyi, A. G., Zhila, N. O., & Shishatskaya, E. I. (2021). Assessment of the efficacy of slow-release formulations of the tribenuron-methyl herbicide in field-grown spring wheat. Environmental science and pollution research international, . https://doi.org/10.1007/s11356-021-17195-x
Volova, Tatiana G, et al. "Assessment of the efficacy of slow-release formulations of the tribenuron-methyl herbicide in field-grown spring wheat." Environmental science and pollution research international vol. (2021). doi: https://doi.org/10.1007/s11356-021-17195-x
Volova TG, Kurachenko NL, Bopp VL, Thomas S, Demidenko AV, Kiselev EG, Baranovsky SV, Sukovatyi AG, Zhila NO, Shishatskaya EI. Assessment of the efficacy of slow-release formulations of the tribenuron-methyl herbicide in field-grown spring wheat. Environ Sci Pollut Res Int. 2021 Nov 02; doi: 10.1007/s11356-021-17195-x. Epub 2021 Nov 02. PMID: 34727312.
Copy Download .nbib Format: NLM
Epidemiological aspects of genital warts in romania - a 2012 retrospective survey.

Maedica

Salavastru CM, Niculescu MC, Zota A, Nicola G, Morariu HS, Solovan C, Patrascu V, Popovici G, Vladuta R, Panduru M, Tiplica GS.
PMID: 25705269
Maedica (Bucur). 2014 Jun;9(2):144-50.

OBJECTIVES: Genital infection with human papillomavirus (HPV) has become one of the most frequently viral sexually transmitted diseases. The infection may remain asymptomatic, may take the form of external genital warts and may give raise to cervical cancers. The...

Cite
Salavastru CM, Niculescu MC, Zota A, et al. Epidemiological aspects of genital warts in romania - a 2012 retrospective survey. Maedica (Bucur). 2014;9(2):144-50
Salavastru, C. M., Niculescu, M. C., Zota, A., Nicola, G., Morariu, H. S., Solovan, C., Patrascu, V., Popovici, G., Vladuta, R., Panduru, M., & Tiplica, G. S. (2014). Epidemiological aspects of genital warts in romania - a 2012 retrospective survey. Maedica, 9(2), 144-50.
Salavastru, Carmen Maria, et al. "Epidemiological aspects of genital warts in romania - a 2012 retrospective survey." Maedica vol. 9,2 (2014): 144-50.
Salavastru CM, Niculescu MC, Zota A, Nicola G, Morariu HS, Solovan C, Patrascu V, Popovici G, Vladuta R, Panduru M, Tiplica GS. Epidemiological aspects of genital warts in romania - a 2012 retrospective survey. Maedica (Bucur). 2014 Jun;9(2):144-50. PMID: 25705269; PMCID: PMC4296756.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 27 entries